gene therapy

Bluebird’s gene therapy for beta-thalassemia falls short of a cure, but still wows in 22 patients
Endpoints
Wed, 04/18/18 - 11:04 pm
Bluebird Bio
beta-thalassemia
gene therapy
[video]Did Novartis Overpay for AveXis?
Motley Fool
Mon, 04/16/18 - 11:34 pm
Novartis
AveXis
gene therapy
M&A
GSK slims portfolio with sale of rare disease gene therapy drugs
Yahoo/Reuters
Thu, 04/12/18 - 12:02 pm
GSK
Orchard Therapeutics
gene therapy
Rare Diseases
Pfizer Commences Ph Ib Trial With Mini-Dystrophin Gene Therapy for the Treatment of Duchenne Muscular Dystrophy
CP Wire
Thu, 04/12/18 - 11:51 am
Pfizer
PF-06939926
Duchenne Muscular Dystrophy
gene therapy
Lonza opens largest gene therapy plant in the world and hires 200 scientists
GoinPharma
Wed, 04/11/18 - 11:30 pm
Lonza
gene therapy
cell therapy
hirings
Why Did Novartis Spend $9 Billion On Gene Therapy? CEO Says: 'A Journey To Focus On Data And Digital'
Forbes
Mon, 04/9/18 - 03:31 pm
Novartis
Vas Narasimhan
M&A
gene therapy
AveXis
Novartis buying AveXis for $8.7 billion to strengthen gene therapy capabilities
Stat
Mon, 04/9/18 - 09:00 am
Novartis
M&A
AveXis
gene therapy
AVXS-101
SMA
spinal muscular atrophy
‘That’s $425,000 right there’ — the anxious launch of a gene therapy with a record sticker price
Stat
Wed, 03/21/18 - 09:23 am
gene therapy
drug pricing
drug launches
Luxturna
Spark Therapeutics
Solid Bio's DMD gene therapy graduates from partial FDA hold to full-on clinical hold
Fierce Biotech
Wed, 03/14/18 - 09:29 pm
Solid Biosciences
gene therapy
FDA
DMD
Duchenne Muscular Dystrophy
Prevail grabs $75M A round in the hunt for new gene therapies to stop the destruction caused by Parkinson’s
Endpoints
Thu, 03/8/18 - 10:28 am
Prevail Therapeutics
gene therapy
Parkinson's Disease
Tiny U.K. Biotech Takes On Glaxo’s $730,000 Gene Therapy
Bloomberg
Tue, 03/6/18 - 09:42 am
gene therapy
bubble boy syndrome
GSK
Strimvelis
Orchard Therapeutics
OTL-101
Spark lays groundwork for US Luxturna launch
Biopharma Dive
Wed, 02/21/18 - 10:58 pm
Spark Therapeutics
Luxturna
drug launches
gene therapy
With $69M Deal, AbbVie Turns to Voyager for an Alzheimer’s Gene Therapy
Xconomy
Tue, 02/20/18 - 10:58 pm
AbbVie
Voyager Therapeutics
gene therapy
Alzheimer's disease
Novartis’ Kymriah: The First Gene Therapy to Be Approved in the US
Market Realist
Mon, 02/19/18 - 09:48 am
Novartis
Kymriah
gene therapy
acute lymphoblastic leukemia
Bioverativ inks $100M gene therapy deal with Oxford BioMedica
Endpoints
Thu, 02/15/18 - 10:06 am
Bioverativ
gene therapy
Oxford BioMedica
Sanofi
Genprex Launch IPO For Trials Of New Gene Therapy Lung Cancer Treatment
Forbes
Mon, 02/5/18 - 11:58 am
Genprex
IPOs
gene therapy
lung cancer
Novartis move signals further gene therapy resurgence
EP Vantage
Fri, 01/26/18 - 11:12 am
Novartis
gene therapy
Spark Therapeutics
CAR-T
Luxturna
Spark licenses blindness gene therapy rights outside U.S. to Novartis
Yahoo/Reuters
Thu, 01/25/18 - 12:00 am
Spark Therapeutics
Novartis
Luxturna
gene therapy
Sarepta is making a bold bet on genetic medicine
Marketwatch
Mon, 01/15/18 - 09:44 am
Sarepta Therapeutics
gene therapy
gene editing
genetic medicine
Drugmakers see a pricing blueprint in an $850,000 gene therapy
Reuters
Fri, 01/12/18 - 06:30 pm
gene therapy
drug pricing
Spark Therapeutics
Luxturna

Pages